Search - tctmd.com

Displaying 201 - 220 of 390

Sort: Relevancy | Date

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

Presentation TCT 2018

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, David E. Thaler

September 24, 2018

Presentation TCT 2018

LAA Closure 3: Prevention and Management of Complications

Presenter: Habib Gamra, E. Murat Tuzcu

September 23, 2018

Presentation TCT 2018

LAA Closure 2: Step-by-step

Presenter: Habib Gamra, E. Murat Tuzcu, Hazem Khamis

September 23, 2018

Presentation TCT 2018

LAA Closure 1: State-of-the-art

Presenter: Habib Gamra, E. Murat Tuzcu

September 23, 2018

Presentation TCT 2018

Case #11: Major Complication of an LAA Closure Procedure in a Frail, Elderly Patient

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #11: An Unexpected Complication During LAA Closure

Presenter: Samir R. Kapadia, Bernard Prendergast, Eric Eeckhout, Ganesh Manoharan, John C. Messenger, Bernhard Reimers, Paul Sorajja, Eric Vang

September 23, 2018

Presentation TCT 2018

Case #9: Management of a Persistent Leak After LAA Closure

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #1: Acute LAA Closure Device Embolization With Challenging Retrieval

Presenter: Maurice Buchbinder, Vivek Y. Reddy

September 23, 2018

Presentation TCT 2018

Featured Presentation: Simultaneous LAA Closure With Structural Heart Procedures - Indications and Postinterventional Management

Presenter: Bagrat Alekyan, Juan F. Granada, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

Considerations for LAA Closure Devices: FDA Perspective

Presenter: Andrew Farb

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

Presenter: Akihide Konishi

September 22, 2018

Presentation TCT 2018

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Presenter: Marek Grygier

September 22, 2018

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

Presentation The Structural Heart Disease Summit 2018

Early and Late PFO Closure Complications

Presenter: John D. Carroll, Brij Maini, Zahid Amin

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Basic and Advanced PFO Closure Techniques

Presenter: John D. Carroll, Brij Maini

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

The Spectrum of PFO Closure Devices: Similarities and Meaningful Differences

Presenter: John D. Carroll, Brij Maini

June 23, 2018

Advertisement

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

LAA Closure 3: Prevention and Management of Complications

LAA Closure 2: Step-by-step

LAA Closure 1: State-of-the-art

Case #11: Major Complication of an LAA Closure Procedure in a Frail, Elderly Patient

Case #11: An Unexpected Complication During LAA Closure

Case #9: Management of a Persistent Leak After LAA Closure

Case #1: Acute LAA Closure Device Embolization With Challenging Retrieval

Featured Presentation: Simultaneous LAA Closure With Structural Heart Procedures - Indications and Postinterventional Management

Considerations for LAA Closure Devices: FDA Perspective

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Novel LAA Closure Device Shows Promise in Early Experience

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Early and Late PFO Closure Complications

Basic and Advanced PFO Closure Techniques

The Spectrum of PFO Closure Devices: Similarities and Meaningful Differences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content